Neuraly is a clinical-stage company whose mission is to discover and develop scientific discoveries in neurology into revolutionary new drugs that can radically improve and prolong the lives of people suffering from the devastating consequences of diseases such as Parkinson’s disease (PD), Alzheimer’s disease (AD) and other neurodegenerative disorders. The company is leveraging a deep understanding of the role of glia biology in neuroinflammation and neuroprotection in advancing a risk-diversified product portfolio for PD and AD.
Company Details
- Employees
- 18
- Founded
- -
- Address
- 704 Quince Orchard Rd.,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- ddpharmatech.com
- HQ
- Gaithersburg, Maryland
Neuraly Inc. Questions
Neuraly Inc.'s website is ddpharmatech.com
Neuraly Inc.'s LinkedIn profile is https://www.linkedin.com/company/neuraly-inc
Neuraly Inc. has
18 employees.
View email and phone details for 18
employees at Neuraly Inc..
Neuraly Inc.'s industry is
Pharmaceutical Manufacturing
Neuraly Inc.'s top competitors are
Metsera,
Valtedseq,
Aardvark Therapeutics,
Bioage Labs,
Terns Pharmaceuticals,
Tonix Pharmaceuticals,
Vector Biomed, Inc.,
D&d Pharmatech,
On Demand Pharmaceuticals Inc,
Xeno Biosciences.
Neuraly Inc.'s categories are Pharmaceutical Manufacturing
Neuraly Inc.'s founding year is 2016
